Decipher Labs Ltd

Thu 3/09/2026,13:16:0 | BSE : DECIPHER

₹5.62-0.01 (-0.18%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 5.65

Previous Close

₹ 5.63

Volume

420

Mkt Cap ( ₹ Cr)

₹ 5.68

High

₹ 5.65

Low

₹ 5.32

52 Week High

₹ 11.20

52 Week Low

₹ 5.00

Book Value Per Share

₹ 6.00

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Decipher Labs Ltd

Your Vote -

Buy

83.33%

Hold

0.00%

Sell

16.67%

83.33%

6 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Decipher Labs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Decipher Labs - Announcements Under Regulation 30 Of SEBI (LODR), Regulations, 2015.

    14 Aug 2026, 6:22PM Announcement under Regulation 30 of SEBI (Listng Obligations and Disclosure Requirement), Regulations, 2015.
  • Decipher Labs - Revised Un-Audited Financial Results For The Quarter Ended 30.06.2026.

    13 Aug 2026, 6:50PM Revised Un-audited Financial Results for the quarter ended 30.06.2026.
  • Decipher Labs - Announcement under Regulation 30 (LODR)-Change in Directorate

    13 Aug 2026, 5:25PM Appointment of Mr. Bhupendralal Waghray as an Additional Director (Independent Category) of the company for a period of Five (5) years w.e.f. 13.08.20
  • Decipher Labs - Financial Results For The Quarter Ended 30.06.2026.

    13 Aug 2026, 5:21PM Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026.
  • Decipher Labs - Board Meeting Outcome for Outcome Of Board Meeting

    13 Aug 2026, 5:15PM Outcome of Board Meeting held on 13th August, 2026.
  • Decipher Labs - Board Meeting Intimation for Meeting Scheduled To Be Held On 13Th August, 2026.

    6 Aug 2026, 5:25PM Decipher Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and ap
  • Decipher Labs has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    17 Jul 2026, 6:10PM As of June 2026, 16.43% is owned by Foreign Promoters and 83.57% by Public. <p align=justify> Top Promoter holding highest number of shares of Deciphe
  • Decipher Labs - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    16 Jul 2026, 5:30PM Compliance as per Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2026

Key fundamentals

Evaluate the intrinsic value of Decipher Labs Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 8.7438 8.7318 8.9276 8.9043 11.5217
Liabilities 8.7438 8.7318 8.9276 8.9043 11.5217
Equity 10.1 10.1 10.1 10.1 10.1
Gross Profit -0.2216 -0.4451 0.0197 -0.3682 0.3621
Net Profit -0.2468 -0.4402 0.0233 -2.6175 0.3604
Cash From Operating Activities -0.2884 0.0749 -0.0297 -0.0765 0.5478
NPM(%) -21.73 -51.59 0.65 -323.14 36.46
Revenue 1.1354 0.8532 3.5316 0.81 0.9884
Expenses 1.357 1.2983 3.5119 1.1782 0.6263
ROE(%) -4.07 -7.26 0.38 -43.22 5.95

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Decipher Labs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 874.00 0.44 21.99 3.21 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 110.00 0.87 1564.14 11.71 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.72 1.09 0.00 24.31 -39.50 0.00
Astec Lifesciences Ltd 575.20 0.51 0.00 12.54 -363.14 0.00

Company Info

M/s. Combat Drugs Limited was incorporated as a Private Limited Company on 18th September, 1986. The Company was converted into a Public Limited Company on llth June, 1992. The Company was promoted by Mr. Suchit Mohan Lal who has vast experience in Marketing of Pharmaceutical Formulations and Mr. Ajay Karan who has experience in the Production as well as Marketing of pharmaceutical formulations. The Commercial Production of the company started in July, 1987 on Loan Licence basis. The company acquired a full fledged manufacturing unit located at Balanagar, Hyderabad on lease from M/s. Fairchild Laboratories Pvt. Ltd. and commenced Production from the said unit in August, 1988. In July, 1992 the Manufacturing activities of the Company were shifted to the present leased premises at 18A, Kushaiguda, Hyderabad. The Lease for the present premises is initially for a period of 3 years w.e.f June, 1992 which can be extended for a further period of 2 years with mutual consent. The total constructed area of 7200 Sft. is conforming to the requirements of a Pharmaceutical Unit and can accomodate Tablet, Capsule and Liquid Sections along with Laboratory, including facilities to manufacture Hi-tec Formulations with little modifications. Utilities like Power, water etc are already available on the Unit. 2011 - the Company have approved the scheme of arrangement between the company and its members and unsecured creditors. 2020 -Company name has changed to Decipher Labs Ltd. from Combat Drugs Ltd.

M/s. Combat Drugs Limited was incorporated as a Private Limited Company on 18th September, 1986. The Company was converted into a Public Limited Company on llth June, 1992. The Company was promoted by Mr. Suchit Mohan Lal who has vast experience in Marketing of Pharmaceutical Formulations and Mr. Ajay Karan who has experience in the Production as well as Marketing of pharmaceutical formulations. The Commercial Production of the company started in July, 1987 on Loan Licence basis. The company acquired a full fledged manufacturing unit located at Balanagar, Hyderabad on lease from M/s. Fairchild Laboratories Pvt. Ltd. and commenced Production from the said unit in August, 1988. In July, 1992 the Manufacturing activities of the Company were shifted to the present leased premises at 18A, Kushaiguda, Hyderabad. The Lease for the present premises is initially for a period of 3 years w.e.f June, 1992 which can be extended for a further period of 2 years with mutual consent. The total constructed area of 7200 Sft. is conforming to the requirements of a Pharmaceutical Unit and can accomodate Tablet, Capsule and Liquid Sections along with Laboratory, including facilities to manufacture Hi-tec Formulations with little modifications. Utilities like Power, water etc are already available on the Unit. 2011 - the Company have approved the scheme of arrangement between the company and its members and unsecured creditors. 2020 -Company name has changed to Decipher Labs Ltd. from Combat Drugs Ltd.

Parent Organisation

Decipher Labs Ltd.

Founded

17/09/1986

Managing Director

NSE Symbol

FAQ